WWHS & Sansure Strategic Partnership in Infrared Fluorescence Diagnostics
On May 15, Academician Dai Hongjie, founder of WWHS Biotech and world-renowned scientist, formally signed a strategic cooperation agreement with Sansure Biotech, and was appointed as Chairman of Sansure Biotech's Global Strategic Technology and Scientific Advisory Panel. This marks the entry of WWHS Biotech's independently developed, globally exclusive infrared fluorescence core technology into a new phase of accelerated industrialization and global adoption.
At the signing ceremony, leaders including Xiao Bailing, Party Group Member and Vice Chairman of the Hunan Provincial Committee of the Chinese People's Political Consultative Conference; Zou Te, Director of the Hunan Xiangjiang New Area (Changsha High-Tech Zone) Management Committee and Mayor of Yuelu District; Zhou Bin, Party Group Member and Deputy Director of the Hunan Provincial Department of Science and Technology; and Li Gemin, Deputy Director of the Hong Kong, Macao, Taiwan, Overseas Chinese and Foreign Affairs Committee of the Hunan Provincial CPPCC, jointly witnessed the event.
Academician Dai Hongjie, founder of WWHS Biotech, currently serves as Dean of the Institute of Life Sciences and Energy Materials Innovation at the University of Hong Kong. He is a member of the US National Academy of Sciences, US National Academy of Medicine, American Academy of Arts and Sciences, and Foreign Member of the Chinese Academy of Sciences, with his research cited over 230,000 times globally. He pioneered the application of infrared fluorescence technology to in vitro diagnostics, establishing the fundamental scientific foundation for precision diagnostics, and leads WWHS Biotech's independent R&D of immunofluorescence detection technology, enabling protein biomarker testing at the primary care level...
